Bicycle Therapeutics PLC (50BA STU) stock market data APIs
€8.4384
0(0%)
as of March 21, 2025
Bicycle Therapeutics PLC Financial Data Overview
Prev. Close
8.4384
Open
8.4384
High
8.4384
Low
8.4384
52 wk Range
8.5-25
Market Cap
1 359 M
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Bicycle Therapeutics PLC data using free add-ons & libraries
Get Bicycle Therapeutics PLC Fundamental Data
Bicycle Therapeutics PLC Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bicycle Therapeutics PLC News
New
Earnings Update: Bicycle Therapeutics plc (NASDAQ:BCYC) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
It's been a good week for Bicycle Therapeutics plc (NASDAQ:BCYC) shareholders, because the company has just released its latest full-year results, and the shares gained 8.6% to US$23.98. Revenues of U...
Bicycle Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Bicycle Therapeutics (NASDAQ:BCYC) Full Year 2023 Results Key Financial Results Revenue: US$27.0m (up 87% from FY 2022). Net loss: US$180.7m (loss widened by 60% from FY 2022). US$5.08 loss per shar...
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
Catalyst-rich 2024 with multiple clinical data readouts and updates expected for pipeline and discovery programs Phase 2/3 Duravelo-2 registrational trial for BT8009 in metastatic urothelial cancer n...
Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
CAMBRIDGE, England & BOSTON, February 07, 2024--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
